Filter
1140
Filtered Results: 1140
Text search:
therapeutic
agents
Featured
Recommendations
145
New Publications
286
Language
Document type
No document type
560
Guidelines
256
Studies & Reports
189
Manuals
62
Strategic & Response Plan
24
Fact sheets
17
Training Material
16
Situation Updates
9
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
76
South Africa
46
Global
41
Kenya
37
Ethiopia
27
Uganda
21
Nigeria
20
Zambia
19
Tanzania
19
Latin America and the Carribbean
17
Nepal
16
Western and Central Europe
16
Sierra Leone
15
Bangladesh
15
Liberia
13
Ghana
12
Rwanda
12
Philippines
11
Namibia
11
Myanmar / Burma
10
Congo, Democratic Republic of
9
Africa
8
Burkina Faso
7
Cambodia
7
Mozambique
7
Russia
7
Germany
6
Malawi
6
Brazil
6
Lesotho
6
USA
5
Cameroon
5
Zimbabwe
5
Indonesia
5
Ukraine
5
Guinea
4
Senegal
4
Mali
4
Haiti
4
Syria
4
Thailand
4
Benin
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Eswatini/ Swaziland
3
North Macedonia
3
Yemen
3
East and Southern Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Vietnam
3
France
3
Spain
3
Pakistan
2
South Sudan
2
Iraq
2
Afghanistan
2
China
2
Sudan
2
Botswana
2
Libya
2
Angola
2
Madagascar
2
Western Pacific Region
2
Paraguay
2
Fiji
2
Bhutan
2
Laos
2
Tajikistan
2
Georgia
2
Gabon
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Somalia
1
Jordan
1
Turkey
1
Malaysia
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Serbia
1
Colombia
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Estonia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
442
Clinical Guidelines
171
Public Health
58
Women & Child Health
46
Key Resources
33
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
AMR
167
COVID-19
82
Mental Health
79
Pharmacy
78
HIV
61
TB
58
NCDs
37
Ebola
36
Caregiver
32
NTDs
32
Rapid Response
31
Planetary Health
16
Disability
12
Refugee
12
Conflict
9
Natural Hazards
8
Specific Hazards
7
Cholera
5
Global Health Education
4
Zika
3
Polio
2
Social Ethics
2
Health Financing Toolbox
2
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer...
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
Reviewed Essential Medicines List July 2021
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Weekly epidemiological update on COVID-19, 28 September 2022
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
